01 10Bristol-Myers Squibb Canada
02 2Gowling WLG (Canada) LLP
01 52250840
02 52317736
03 12678907
04 12720856
01 4ATAZANAVIR SULFATE | COBICISTAT
02 8Atazanavir Sulfate
01 8Capsule
02 4TABLET
01 52017-04-14
02 52018-12-22
03 12028-02-22
04 12029-05-01
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
Brand Name : REYATAZ
Patent Number : 2317736
Filing Date : 1998-12-22
Strength per Unit : 100 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Brand Name : REYATAZ
Patent Number : 2250840
Filing Date : 1997-04-14
Strength per Unit : 100 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
Brand Name : REYATAZ
Patent Number : 2317736
Filing Date : 1998-12-22
Strength per Unit : 150 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Brand Name : REYATAZ
Patent Number : 2250840
Filing Date : 1997-04-14
Strength per Unit : 150 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
Brand Name : REYATAZ
Patent Number : 2317736
Filing Date : 1998-12-22
Strength per Unit : 200 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Brand Name : REYATAZ
Patent Number : 2250840
Filing Date : 1997-04-14
Strength per Unit : 200 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
ATAZANAVIR SULFATE, COBICISTAT
Brand Name : EVOTAZ
Patent Number : 2250840
Filing Date : 1997-04-14
Strength per Unit : 300 mg / 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
ATAZANAVIR SULFATE, COBICISTAT
Brand Name : EVOTAZ
Patent Number : 2317736
Filing Date : 1998-12-22
Strength per Unit : 300 mg / 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
Patent Expiration Date : 2028-02-22
Date Granted : 2014-06-17
ATAZANAVIR SULFATE, COBICISTAT
Brand Name : EVOTAZ
Patent Number : 2678907
Filing Date : 2008-02-22
Strength per Unit : 300 mg / 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-02-22
Date Granted : 2014-06-17
Patent Expiration Date : 2029-05-01
Date Granted : 2016-02-02
ATAZANAVIR SULFATE, COBICISTAT
Brand Name : EVOTAZ
Patent Number : 2720856
Filing Date : 2009-05-01
Strength per Unit : 300 mg / 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-05-01
Date Granted : 2016-02-02
